17 / 36
OS by level of greatest confirmed PSA decline from baseline
within the first 90 days of treatment with enzalutamide
rPFS by level of greatest confirmed PSA decline from baseline
within the first 90 days of treatment with enzalutamide
Armstrong AJ et al. Cancer.2017;123: 2303-11
Clinical outcomes and survival surrogacy studies
of PSA declines with Enza